Did US aid cuts break precisely the things we need most for the lenacapavir rollout?

Posted in: Healthcare system, HIV, Latest, Spotlight

With a new six-monthly injection, South Africa last week launched the most promising new HIV prevention tool in years, but much of the infrastructure that made HIV prevention services accessible to high-risk groups has been dismantled over the last year. Amy Green asks whether we can successfully deliver this breakthrough technology without the trusted pathways that were decimated by cuts to aid from the United States.

Did US aid cuts break precisely the things we need most for the lenacapavir rollout?

The evolution of HIV treatment: From multi-pill regimens to better, single pill combos

Posted in: HIV, Latest, Spotlight

HIV treatment has been improved and simplified significantly over the years yet a small fraction of people living with HIV still take complex multi-pill regimens. Elri Voigt reports on a new combination pill that could make life easier for some in this group. But as two leading experts point out, the development comes against a backdrop where the traditional categorisation of HIV medicines is dissolving.

The evolution of HIV treatment: From multi-pill regimens to better, single pill combos

What breakthrough weight loss meds might mean for people with HIV

Posted in: Healthcare system, HIV, Latest, NCDs, Spotlight

In part 3 of a Spotlight special series on the role of new weight loss medicines like Ozempic in South Africa, we ask what these breakthrough jabs might mean for people living with HIV in the country. There is some tantalising early research on potential benefits, but also many uncertainties. Catherine Tomlinson reports.

What breakthrough weight loss meds might mean for people with HIV

Dragon slayer in a time of dragons: Dr Nomathemba Chandiwana battles ‘SA’s new HIV epidemic’

Posted in: Healthcare system, HIV, Latest, Spotlight

The obesity epidemic will hit South Africa hard on top of our high HIV burden, but advocate researcher and scientist Dr Nomathemba Chandiwana says she is ready to fight back harder. She speaks to Ufrieda Ho about her journey from working in state hospitals to transitioning into obesity medicine, and her move to Cape Town.

Dragon slayer in a time of dragons: Dr Nomathemba Chandiwana battles ‘SA’s new HIV epidemic’

Francois Venter | Slow motion denialism: Our leaders are allowing the HIV response to collapse

Posted in: Healthcare system, HIV, Latest, Opinions, Spotlight, TB

South Africa is staging a sequel to Mbeki-era denialism, only this time, the science, solutions, and costs are clearer, argues Professor Francois Venter.

Francois Venter | Slow motion denialism: Our leaders are allowing the HIV response to collapse

The way we understand obesity is changing: What does it mean for South Africa?

Posted in: Latest, NCDs, Spotlight

Health workers have long relied on Body Mass Index (BMI) as a way to measure whether people are within a healthy weight range. Now, a collection of top researchers have made the case for a new way to understand and diagnose obesity. In part two of this special Spotlight series, we take a look at what this new framing might mean for South Africa.

The way we understand obesity is changing: What does it mean for South Africa?

Francois Venter | Our HIV programme is collapsing — and our government is nowhere to be seen

Posted in: Healthcare system, HIV, Latest, Opinions, Perspectives, Spotlight, TB

We’re watching the largest HIV treatment programme in the world unravelling in real time. We don’t need perfection, but we do need a combination of urgency, action, and strategy to save it, argues Professor Francois Venter.

Francois Venter | Our HIV programme is collapsing — and our government is nowhere to be seen

How much does our HIV response depend on US funding?

Posted in: Healthcare system, HIV, Latest, Spotlight

After the US slashed global aid, the South African government stated that only 17% of its HIV spending relied on US funding. But some experts argue that US health initiatives had more bang for buck than the government’s programmes. Jesse Copelyn looks past the 17% figure, and considers how the health system is being affected by the loss of US money.

How much does our HIV response depend on US funding?

SA unveils ambitious new HIV campaign amid aid crisis

Posted in: Healthcare system, HIV, Latest, Spotlight

Amid major disruptions caused by aid cuts from the United States government, the health department aims to enrol a record number – an additional 1.1 million – of people living with HIV on life-saving antiretroviral medicine this year. Experts tell Spotlight it can’t be business as usual if this ambitious programme is to have a chance of succeeding. Ufrieda Ho reports.

SA unveils ambitious new HIV campaign amid aid crisis

Francois Venter | Our HIV response will collapse without US funding – unless we act urgently

Posted in: Healthcare system, HIV, Latest, Opinions, Perspectives, Spotlight, TB

South Africa faces its worst health crisis in 20 years. Worse than COVID, and one that will overshadow diabetes as a major killer, while pouring petrol on a dwindling TB fire. But it is preventable, argues Professor Francois Venter if our government steps up urgently.

Francois Venter | Our HIV response will collapse without US funding – unless we act urgently

Which of the breakthrough weight loss medicines can you get in SA?

Posted in: Healthcare system, Latest, NCDs, Spotlight

The remarkable efficacy of new diabetes and weight loss medicines like Ozempic and Mounjaro have been one of the biggest health stories of recent years. Despite rising rates of diabetes and obesity, access to these medicines remain limited in South Africa. Catherine Tomlinson asks which of the GLP-1 agonists are available here and at what price.

Which of the breakthrough weight loss medicines can you get in SA?

South Africa’s AIDS response: Progress, challenges, and opportunities

Posted in: Healthcare system, HIV, Latest, Opinions, Perspectives, Spotlight

Ahead of World AIDS Day 2024, Professor Salim Abdool Karim and Dr Nikita Devnarain argue that South Africa needs a concerted effort to reduce new HIV infections in young women and to prepare for the rollout of long-acting forms of HIV prevention alongside a well-functioning HIV treatment programme.